VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Oaktree Acquisition Corp. III Life Sciences (OACC) Total Return Calculator with Dividends Reinvested

Oaktree Acquisition Corp. III Life Sciences

Popular:

The total return for Oaktree Acquisition Corp. III Life Sciences (OACC) stock is +1.43% over the past 12 months. So far it's down 0.05% this year. The 5-year total return is +6.10%, meaning $10,000 invested in OACC stock 5 years ago would be worth $10,610 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in OACC 1 year ago, it would be worth $10,153 today — you'd have gained $153.

With Dividends Reinvested$10,153+1.53%

Price Only (No DRIP)$10,153+1.53%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in OACC

1Y$10,143+$143 (+1.4%)1.4% CAGR

3Y$10,610+$610 (+6.1%)2.0% CAGR

5Y$10,610+$610 (+6.1%)1.2% CAGR

10Y$10,610+$610 (+6.1%)0.6% CAGR

15Y$10,610+$610 (+6.1%)0.4% CAGR

20Y$10,610+$610 (+6.1%)0.3% CAGR

30Y$10,610+$610 (+6.1%)0.2% CAGR

Oaktree Acquisition Corp. III Life Sciences did not pay dividends during this period. Total return = price return.

Loading OACC total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-0.05%	—	-0.05%	—	$9,995
1Y	+1.43%	1.43%	+1.43%	—	$10,143
3Y	+6.10%	1.99%	+6.10%	—	$10,610
5Y	+6.10%	1.19%	+6.10%	—	$10,610
10Y	+6.10%	0.59%	+6.10%	—	$10,610
15Y	+6.10%	0.40%	+6.10%	—	$10,610
20Y	+6.10%	0.30%	+6.10%	—	$10,610
30Y	+6.10%	0.20%	+6.10%	—	$10,610

Risk & Highlights

Best Year+6.12%2025

Worst Year-0.40%2024

Max Drawdown-2.74%2025-06-20 → 2025-08-15 · Recovered 2025-10-14

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+0.19%	+0.19%	—	+0.41%	-0.2pp
2025	+6.12%	+6.12%	—	+16.64%	-10.5pp
2024	-0.40%	-0.40%	—	+24.00%	-24.4pp

OACC underperformed the S&P 500 by 28.94pp over the past year (+1.43% vs +30.37%).

Loading summary...

OACC Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
OACCOaktree Acquisition Corp. III Life Sciences	$261M	+0.1%	-0.0%	+1.4%	—	+6.1%	+6.1%	+6.1%
RLAYRelay Therapeutics, Inc.	$2.4B	-7.2%	+52.9%	+324.1%	—	+15.6%	-57.6%	-64.3%
BCTXBriaCell Therapeutics Corp.	$5M	-7.4%	-42.8%	-87.5%	—	-99.6%	-99.2%	—
RXRXRecursion Pharmaceuticals, Inc.	$1.5B	+2.5%	-22.1%	-22.0%	—	-41.6%	-88.2%	-81.8%
BFLYButterfly Network, Inc.	$1.1B	+4.7%	+13.1%	+94.5%	—	+100.9%	-65.1%	-57.2%
GHGuardant Health, Inc.	$12.1B	-1.1%	-9.3%	+132.2%	—	+292.1%	-31.9%	+186.5%
EXASExact Sciences Corporation	$20.0B	—	+3.1%	+96.9%	—	+53.0%	+0.4%	+1669.1%
NVAXNovavax, Inc.	$1.5B	+15.7%	+29.5%	+55.1%	—	+23.9%	-94.8%	-90.4%
BEAMBeam Therapeutics Inc.	$3.2B	+28.5%	+16.0%	+93.9%	—	-5.6%	-55.6%	+67.8%
CRSPCRISPR Therapeutics AG	$5.1B	+5.5%	-2.5%	+53.1%	—	-6.3%	-51.3%	+272.0%
NTLAIntellia Therapeutics, Inc.	$1.6B	+1.2%	+48.9%	+88.1%	—	-68.3%	-79.8%	-42.9%

Compare:OACC vs RLAY OACC vs BCTX OACC vs RXRX OACC vs RLAY vs BCTX

About OACC Dividend Returns

Oaktree Acquisition Corp. III Life Sciences (OACC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of OACC over the past year?

Oaktree Acquisition Corp. III Life Sciences (OACC) delivered a return of 1.43% over the past year. Since OACC does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in OACC be worth today?

A $10,000 investment in Oaktree Acquisition Corp. III Life Sciences one year ago would be worth $10,143 today, representing a gain of $143.

Q3Does OACC pay dividends?

Oaktree Acquisition Corp. III Life Sciences (OACC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For OACC, the total return equals the price-only return.

Q4Did OACC beat the S&P 500?

No, Oaktree Acquisition Corp. III Life Sciences (OACC) underperformed the S&P 500 by 28.94 percentage points over the past year. OACC delivered a total return of 1.43%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed OACC by 28.94pp during this period.

Q5What is OACC's worst drawdown?

Oaktree Acquisition Corp. III Life Sciences (OACC) experienced a maximum drawdown of -2.74% over the past year, declining from its peak on 2025-06-20 to its trough on 2025-08-15. The stock recovered to its prior peak by 2025-10-14. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is OACC's long-term total return over 10, 20, or 30 years?

Here are Oaktree Acquisition Corp. III Life Sciences (OACC)'s long-term returns with dividends reinvested. Over 10 years, the total return is 6.1% (0.6% CAGR) — $10,000 would have grown to $10,610. Over 20 years: 6.1% total return (0.3% CAGR) — $10,000 → $10,610. Over 30 years: 6.1% total return (0.2% CAGR) — $10,000 → $10,610. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was OACC's best and worst year?

Oaktree Acquisition Corp. III Life Sciences's best calendar year was 2025 with a total return of 6.1%. Its worst year was 2024 with a total return of -0.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 6.5 percentage points.